PEGASYS® (Peginterferon Alfa-2a (40KD)) Plus COPEGUS® (Ribavirin)

DRUG2 trials

Sponsors

Baqiyatallah Medical Sciences University

Conditions

HemophiliaHepatitis CThalassemia

Phase 4

Pegasys® Plus Ribavirin in Thalassemic Patients With Hepatitis C Virus Infection

CompletedNCT00707850

Baqiyatallah Medical Sciences UniversityHepatitis C, Thalassemia

Start: 2007-05-31End: 2009-09-30Target: 300Updated: 2010-08-31

Pegasys® Plus Ribavirin in Hemophilic Patients With Hepatitis C Virus Infection

CompletedNCT00707772

Baqiyatallah Medical Sciences UniversityHemophilia, Hepatitis C

Start: 2007-03-31End: 2009-09-30Target: 400Updated: 2009-09-17